PharmaJet, the developer of a needle-free injection technology to administer medications and vaccines to patients, and bioCSL, the maker of Afluria (influenza vaccine) on Tuesday announced the Food and Drug Administration has approved the PharmaJet Stratis 0.5mL Needle-Free Jet Injector for delivery of Afluria in individuals ages 18 years to 64 years.
Bartell Drugs on Monday announced the launch of a seasonal flu vaccination program, which offers in-store vaccinations at 63 Bartell Drug locations, as well as an off-site flu clinic program that serves area businesses and retirement communities.
High-dose influenza vaccine is 24% more effective than the standard-dose vaccine in protecting persons ages 65 and older against influenza illness and its complications, according to a Vanderbilt-led study published Wednesday in the New England Journal of Medicine.
GSK has begun shipping Fluarix Quadrivalent (influenza vaccine) doses to U.S. healthcare providers, the company annouced. This marks the first shipment of GSK's U.S. flu vaccine supply for the flu season, which follows licensing and lot-release approval from the Food and Drug Administration's Center for Biologics Evaluation and Research.
According to a report from the American Academy of Family Physicians, the Advisory Committee on Immunization Practices for the Centers for Disease Control and Prevention voted unanimously to recommend that healthy children between the ages of 2 years and 8 years be inoculated with a live attenuated influenza vaccine like FluMist, as opposed to the traditional flu shot.
The Advisory Committee on Immunization Practices on Wednesday voted to recommend a preference for using the nasal spray flu vaccine instead of the flu shot in healthy children ages 2 years to 8 years of age when it is immediately available.
A report published Friday in the Morbidity and Mortality Weekly Report characterized the 2013-2014 influenza season as the first season since 2009 that H1N1 generated fewer levels of outpatient illness and mortality as compared with seasons when influenza A (H3N2) is predominant.
A new study from the Centers for Disease Control and Prevention found that flu vaccines prevent flu-associated hospitalizations in people 65 years and older, even during seasons when vaccine effectiveness is low, the agency stated Friday.
Getting a flu vaccine reduces a child’s risk of flu-related intensive care hospitalization by 74%, according to a Centers for Disease Control and Prevention study published Thursday in the Journal of Infectious Diseases.
The highest prevalence of influenza happens among those professions that are exposed to the general public, such as real estate and rental and leasing (10.5% in this profession were at risk of flu according to a recent study published Friday in the Morbidity and Mortality Weekly Report) and accommodation and food services (10.2%).
The American Pharmacists Association has completed its 2013 Pharmacy-based Influenza and Adult Immunization Survey and found an increase in the administration of numerous vaccines by pharmacists, a growing network of patient referral relationships and steps being taken toward improved documentation practices, the Association has announced.
Only one-third of adults between the ages of 18 and 64 have gotten their flu shot this season, which is a contributing factor to why this year's flu activity has hit young adults particularly hard, according to Tom Frieden, director of the Centers for Disease Control and Prevention.